Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

NCT00160160 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Type 2 Diabetes

Interventions

DRUG: eprosartan/HCTZ

Sponsor

Solvay Pharmaceuticals